Risperidone versus placebo for aggression following traumatic brain injury: a feasibility randomised controlled trial

Risperidone versus placebo for aggression following traumatic brain injury: a feasibility randomised controlled trial

Objectives To conduct a feasibility randomised controlled trial of risperidone for the treatment of aggression in adults with traumatic brain injury (TBI).Design Multicentre, parallel design, placebo controlled (1:1 ratio) double-blind feasibility trial with an embedded process evaluation. No statis...

Full description

Saved in:
Bibliographic Details
Main Authors: Paul Bassett, Tim Weaver, Shoumitro Deb, Mike Crawford, David Sharp, Lina Aimola, Verity Leeson, Mayur Bodani, Lucia Li
Format: Article
Language:English
Published: BMJ Publishing Group 2020-09-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/10/9/e036300.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items